WS #10121
Pfizer reaffirms FY26 guidance after CFO transition announcement, providing stability to the stock.
Pfizer Reaffirms Guidance After CFO Transition
Pfizer reaffirms FY26 guidance after CFO transition announcement, providing stability to the stock.